Trial
NCT00836069
Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cedars-Sinai Medical Center
Collaborators
Pfizer
Condition
Anxiety Disorders
Intervention
No drug name provided by Sponsor
Why stopped
Pfizer has terminated the execution of this protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-21